Upgrade to SI Premium - Free Trial

Amgen (AMGN) PT Raised to $272 at UBS

October 30, 2023 9:21 AM
UBS analyst Colin Bristow raised the price target on Amgen (NASDAQ: AMGN) to $272.00 (from $260.00) while maintaining a Neutral rating.

Categories

Analyst PT Change

Next Articles